Wenjie Y. Ge
Harbin, 150036, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Intracranial Langerhans-cell histiocytosis that is not coocurring with Erdheim-Chester disease: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: October 29, 2023
Mixed epithelial and stromal tumor of kidney complicated with renal oncocytomatosis: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: September 13, 2022
Nuclear iASPP determines cell fate by selectively inhibiting either p53 or NF-κB.
Journal: Cell death discovery
Published: May 19, 2021
A novel LncRNA HITT forms a regulatory loop with HIF-1α to modulate angiogenesis and tumor growth.
Journal: Cell death and differentiation
Published: February 18, 2019
HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma.
Journal: Cancer letters
Published: March 29, 2018
Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
Journal: International journal of cancer
Published: December 22, 2016
Upregulation of MiR-205 under hypoxia promotes epithelial-mesenchymal transition by targeting ASPP2.
Upregulation of MiR-205 under hypoxia promotes epithelial-mesenchymal transition by targeting ASPP2.
Journal: Cell death & disease
Published: July 29, 2016
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
Journal: Oncotarget
Published: July 09, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026